Widespread neuron-specific transgene expression in brain and spinal cord following synapsin promoter-driven AAV9 neonatal intracerebroventricular injection

被引:74
作者
McLean, Jesse R. [1 ]
Smith, Gaynor A. [1 ]
Rocha, Emily M. [1 ]
Hayes, Melissa A. [1 ]
Beagan, Jonathan A. [1 ]
Hallett, Penelope J. [1 ]
Isacson, Ole [1 ]
机构
[1] Harvard Univ, Sch Med, Neuroregenerat Inst, McLean Hosp, Belmont, MA 02478 USA
关键词
AAV9; Neurodegeneration; Gene delivery; ALS; Parkinson's disease; Alzheimer's disease; GENE-TRANSFER; RAT-BRAIN; DELIVERY; VECTORS; MODEL; MICE; TRANSDUCTION; PATTERNS; THERAPY; TROPISM;
D O I
10.1016/j.neulet.2014.05.044
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Adeno-associated viral (AAV) gene transfer holds great promise for treating a wide-range of neurodegenerative disorders. The AAV9 serotype crosses the blood brain barrier and shows enhanced transduction efficiency compared to other serotypes, thus offering advantageous targeting when global transgene expression is required. Neonatal intravenous or intracerebroventricular (i.c.v.) delivery of recombinant AAV9 (rAAV9) have recently proven effective for modeling and treating several rodent models of neurodegenerative disease, however, the technique is associated with variable cellular tropism, making tailored gene transfer a challenge. In the current study, we employ the human synapsin 1 (hSYN1) gene promoter to drive neuron-specific expression of green fluorescent protein (GFP) after neonatal i.c.v. injection of rAAV9 in mice. We observed widespread GFP expression in neurons throughout the brain, spinal cord, and peripheral nerves and ganglia at 6 weeks-of-age. Region-specific quantification of GFP expression showed high neuronal transduction rates in substantia nigra pars reticulata (43.9 +/- 5.4%), motor cortex (43.5 +/- 3.3%), hippocampus (43.1 +/- 2.7%), cerebellum (29.6 +/- 2.3%), cervical spinal cord (24.9 +/- 3.9%), and ventromedial striatum (16.9 4.3%), among others. We found that 14.6 +/- 2.2% of neuromuscular junctions innervating the gastrocnemius muscle displayed GFP immunoreactivity. GFP expression was identified in several neuronal sub-types, including nigral tyrosine hydroxylase (TH)-positive dopaminergic cells, striatal dopamine-and cAMP-regulated neuronal phosphoprotein (DARPP-32)-positive neurons, and choline acetyltransferase (ChAT)-positive motor neurons. These results build on contemporary gene transfer techniques, demonstrating that the hSYN1 promoter can be used with rAAV9 to drive robust neuron-specific transgene expression throughout the nervous system. (C) 2014 The Authors. Published by Elsevier Ireland Ltd.
引用
收藏
页码:73 / 78
页数:6
相关论文
共 37 条
[1]   Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain [J].
Aschauer, Dominik F. ;
Kreuz, Sebastian ;
Rumpel, Simon .
PLOS ONE, 2013, 8 (09)
[2]   Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients [J].
Bartus, Raymond T. ;
Baumann, Tiffany L. ;
Siffert, Joao ;
Herzog, Christopher D. ;
Alterman, Ron ;
Boulis, Nicholas ;
Turner, Dennis A. ;
Stacy, Mark ;
Lang, Anthony E. ;
Lozano, Andres M. ;
Olanow, C. Warren .
NEUROLOGY, 2013, 80 (18) :1698-1701
[3]   Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system [J].
Burger, C ;
Gorbatyuk, OS ;
Velardo, MJ ;
Peden, CS ;
Williams, P ;
Zolotukhin, S ;
Reier, PJ ;
Mandel, RJ ;
Muzyczka, N .
MOLECULAR THERAPY, 2004, 10 (02) :302-317
[4]   Expanded repertoire of AAV vector serotypes mediate unique patterns of transduction in mouse brain [J].
Cearley, Cassia N. ;
Vandenberghe, Luk H. ;
Parente, Michael K. ;
Carnish, Erin R. ;
Wilson, James M. ;
Wolfe, John H. .
MOLECULAR THERAPY, 2008, 16 (10) :1710-1718
[5]   Capsid Serotype and Timing of Injection Determines AAV Transduction in the Neonatal Mice Brain [J].
Chakrabarty, Paramita ;
Rosario, Awilda ;
Cruz, Pedro ;
Siemienski, Zoe ;
Ceballos-Diaz, Carolina ;
Crosby, Keith ;
Jansen, Karen ;
Borchelt, David R. ;
Kim, Ji-Yoen ;
Jankowsky, Joanna L. ;
Golde, Todd E. ;
Levites, Yona .
PLOS ONE, 2013, 8 (06)
[6]  
Chen HF, 2011, METHODS MOL BIOL, V737, P235, DOI 10.1007/978-1-61779-095-9_10
[7]   Dynamic Changes in Presynaptic and Axonal Transport Proteins Combined with Striatal Neuroinflammation Precede Dopaminergic Neuronal Loss in a Rat Model of AAV α-Synucleinopathy [J].
Chung, Chee Yeun ;
Koprich, James B. ;
Siddiqi, Hasan ;
Isacson, Ole .
JOURNAL OF NEUROSCIENCE, 2009, 29 (11) :3365-3373
[8]   Selective Forelimb Impairment in Rats Expressing a Pathological TDP-43 25 kDa C-terminal Fragment to Mimic Amyotrophic Lateral Sclerosis [J].
Dayton, Robert D. ;
Gitcho, Michael A. ;
Orchard, Elysse A. ;
Wilson, Jon D. ;
Wang, David B. ;
Cain, Cooper D. ;
Johnson, Jeffrey A. ;
Zhang, Yong-Jie ;
Petrucelli, Leonard ;
Mathis, J. Michael ;
Klein, Ronald L. .
MOLECULAR THERAPY, 2013, 21 (07) :1324-1334
[9]   The advent of AAV9 expands applications for brain and spinal cord gene delivery [J].
Dayton, Robert D. ;
Wang, David B. ;
Klein, Ronald L. .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (06) :757-766
[10]  
Dirren E., 2014, HUM GENE THER